Zivo Bioscience Stock Total Asset
| ZIVODelisted Stock | USD 1.81 0.01 0.55% |
Zivo Bioscience fundamentals help investors to digest information that contributes to Zivo Bioscience's financial success or failures. It also enables traders to predict the movement of Zivo Stock. The fundamental analysis module provides a way to measure Zivo Bioscience's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Zivo Bioscience stock.
Zivo |
Zivo Bioscience Company Total Asset Analysis
Zivo Bioscience's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current Zivo Bioscience Total Asset | 2.12 M |
Most of Zivo Bioscience's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Zivo Bioscience is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
CompetitionBased on the latest financial disclosure, Zivo Bioscience has a Total Asset of 2.12 M. This is 99.97% lower than that of the Personal Care Products sector and 99.89% lower than that of the Consumer Staples industry. The total asset for all United States stocks is 99.99% higher than that of the company.
Zivo Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Zivo Bioscience's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Zivo Bioscience could also be used in its relative valuation, which is a method of valuing Zivo Bioscience by comparing valuation metrics of similar companies.Zivo Bioscience is currently under evaluation in total asset category among its peers.
Zivo Fundamentals
| Return On Equity | -39.56 | ||||
| Return On Asset | -1.65 | ||||
| Operating Margin | (133.25) % | ||||
| Current Valuation | 2.02 M | ||||
| Shares Outstanding | 1.82 M | ||||
| Shares Owned By Insiders | 25.23 % | ||||
| Shares Owned By Institutions | 4.44 % | ||||
| Number Of Shares Shorted | 35.47 K | ||||
| Price To Earning | (1.95) X | ||||
| Price To Book | 17.86 X | ||||
| Price To Sales | 2,639 X | ||||
| Gross Profit | 20 K | ||||
| EBITDA | (8.73 M) | ||||
| Net Income | (8.75 M) | ||||
| Cash And Equivalents | 5.08 M | ||||
| Cash Per Share | 0.54 X | ||||
| Total Debt | 445.18 K | ||||
| Debt To Equity | 0.28 % | ||||
| Current Ratio | 2.08 X | ||||
| Book Value Per Share | (0.63) X | ||||
| Cash Flow From Operations | (7.1 M) | ||||
| Short Ratio | 6.65 X | ||||
| Earnings Per Share | (5.33) X | ||||
| Target Price | 36.0 | ||||
| Beta | 0.27 | ||||
| Market Capitalization | 2 M | ||||
| Total Asset | 2.12 M | ||||
| Retained Earnings | (115.8 M) | ||||
| Working Capital | (126.04 K) | ||||
| Current Asset | 28.93 K | ||||
| Current Liabilities | 4.97 M | ||||
| Z Score | -87.31 | ||||
| Annual Yield | 0.04 % | ||||
| Net Asset | 2.12 M |
About Zivo Bioscience Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Zivo Bioscience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zivo Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zivo Bioscience based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Zivo Bioscience
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Zivo Bioscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zivo Bioscience will appreciate offsetting losses from the drop in the long position's value.Moving together with Zivo Stock
Moving against Zivo Stock
| 0.75 | FRTX | Fresh Tracks Therapeutics | PairCorr |
| 0.74 | VAXX | Vaxxinity | PairCorr |
| 0.7 | EPRX | Eupraxia Pharmaceuticals | PairCorr |
| 0.65 | EVLO | Evelo Biosciences | PairCorr |
| 0.62 | NAMSW | NewAmsterdam Pharma Downward Rally | PairCorr |
The ability to find closely correlated positions to Zivo Bioscience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Zivo Bioscience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Zivo Bioscience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Zivo Bioscience to buy it.
The correlation of Zivo Bioscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Zivo Bioscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Zivo Bioscience moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Zivo Bioscience can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Consideration for investing in Zivo Stock
If you are still planning to invest in Zivo Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Zivo Bioscience's history and understand the potential risks before investing.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |